消除梅毒母婴传播：中国在COVID-19大流行前和流行期间的实践经验

doi:10.24920/003903

摘要/Abstract

摘要：

在许多发展中国家,梅毒的母婴传播（mother-to-child transmission,MTCT）仍然是新生儿死产和死亡的主要原因。2007年,世界卫生组织启动了全球消除梅毒MTCT的计划。鉴于先天性梅毒的高疾病负担,中国随后发布了国家梅毒EMTCT政策和方案,以减少梅毒的MTCT。中国的先天性梅毒报告发病率由2013年的69.9例/10万活产下降到2019年的12.0例/10万活产。当前在新型冠状病毒肺炎（COVID-19）全球大流行期间,消除梅毒MTCT领域的工作进展受到拖延,使消除和终止梅毒MTCT的计划面临巨大挑战。本文总结了近20年来中国在消除梅毒MTCT的策略和措施,指出在国家卫生政策的支持和政府的坚强领导下,中国消除梅毒MTCT取得了显著的成就。在COVID-19大流行期间,加强对区域性暴发的COVID-19疫情的应急响应,采用安全、快速、早期和高质量的临床护理,确保100%的孕妇获得产前梅毒检测服务,确保治疗用苄星青霉素的药物供给,加强对感染梅毒孕妇和新生儿的闭环管理,是决定梅毒MTCT效果的关键措施。中国的经验教训可能对其他正在计划消除梅毒MTCT的国家有借鉴价值。

关键词: 母婴阻断, 梅毒, 新型冠状病毒肺炎, 中国

Abstract:

Mother-to-child transmission (MTCT) of syphilis remains a leading cause of stillbirth and death among neonates in many developing countries. In 2007, World Health Orgernization launched the global elimination of MTCT (EMTCT) of syphilis. Given the high burden of congenital syphilis, China subsequently released the specific national EMTCT policies and programs to reduce MTCT of syphilis. The congenital syphilis incidence rate per 100,000 live births in China has markedly decreased from 69.9 in 2013 to 11.9 in 2019. However, due to the global pandemic of COVID-19, the current measures for eliminating MTCT of syphilis are greatly challenged. In this article, we summarize the strategies and measures for the EMTCT of syphilis in China in the past 20 years, the remarkable achievements by the policy support under the leadership of the government. In the context of COVID-19 pandemics, strengthening emergency response to the regional outbreaks of COVID-19, adopting safe, rapid, early and high-quality clinical care for 100% of pregnant women to receive prenatal syphilis testing services, ensuring the availability of Benzathine penicillin for the treatment, and strengthening the closed-loop management of pregnant women and newborns infected with syphilis are the key measures to determine the effectiveness of MTCT for syphilis. Lessons from China may be valuable for other countries that are planning to eliminate MTCT of syphilis.

Key words: mother-to-child transmission, syphilis, COVID-19, China

基金资助: 中国医学科学院联合创新团队项目(2016-I2M-3021);国家自然科学基金项目(81772209);国家自然科学基金项目(81601804);南京市国家级临床医学中心培育计划项目(2019060001)

Fangzhi Du, Ruili Zhang, Qianqiu Wang. Eliminating Mother-to-Child Transmission of Syphilis: Chinese Practice before and during COVID-19 Pandemics[J].Chinese Medical Sciences Journal, 2022, 37(1): 67-72.

参考文献 26.

1.	Newman L, Kamb M, Hawkes S, et al. Global estimates of syphilis in pregnancy and associated adverse outcomes: analysis of multinational antenatal surveillance data. PLoS Med 2013; 10(2):e1001396. doi: 10.1371/journal.pmed.1001396. doi: 10.1371/journal.pmed.1001396
2.	Zhang X, Yu Y, Yang H, et al. Surveillance of maternal syphilis in China: pregnancy outcomes and determinants of congenital syphilis. Med Sci Monit 2018; 24:7727-35. doi: 10.12659/MSM.910216. doi: 10.12659/MSM.910216
3.	Wijesooriya NS, Rochat RW, Kamb ML, et al. Global burden of maternal land congenital syphilis in 2008 and 2012: a health systems modelling study. Lancet Glob Health 2016; 4(8):e525-33. doi: 10.1016/S2214-109X(16)30135-8. doi: 10.1016/S2214-109X(16)30135-8
4.	World Health Organization. The global elimination of congenital syphilis: rationale and strategy for action. Available from https://www.who.int/publications/i/item/the-global-elimination-of-congenital-syphilis-rationale-and-strategy-for-action. Accessed March 10, 2021.
5.	World Health Organization. Global Sexually Transmitted Infections Programme. Mother-to-child transmission of syphilis. Available from https://www.who.int/reproductivehealth/congenital-syphilis/en/. Accessed March 10, 2021.
6.	Zhang XY, Li M, Feng YB, et al. Meta-analysis of effect of prevention of mother to child transmission of HIV during 2011-2014 in China. Chin J AIDS STD 2015; 21(4):275-9. doi: 10.13419/j.cnki.aids.2015.04.06. doi: 10.13419/j.cnki.aids.2015.04.06
7.	Wu X, Feng T, Yu W. Prevention of mother-to-child transmission of syphilis: technical measures and effectiveness. Electr J Emerging Infect Dis 2019; 4(4):204-8. doi: 10.19871/j.cnki.xfcrbzz.2019.04.004. doi: 10.19871/j.cnki.xfcrbzz.2019.04.004
8.	Yue XL, Gong XD, Li J, et al. Trends and epidemiologic features of syphilis in China, 2014-2019. Chin J Dermatol 2021; 54(7):47-51. doi: 10.35541/cjd.20210098. doi: 10.35541/cjd.20210098
9.	Ministry of Health, People’s Republic of China. Report on women and children’s health development in China (2011). Available from http://www.gov.cn/gzdt/att/att/site1/20110921/001e3741a4740fe3bdbf02.pdf. Accessed March 10, 2021.
10.	Wu Z, Sullivan SG, Wang Y, et al. Evolution of China’s response to HIV/AIDS. Lancet 2007; 369(9562):679-90. doi: 10.1016/S0140-6736(07)60315-8. doi: 10.1016/S0140-6736(07)60315-8
11.	Embassy of the People’s Republic of China in the United State of America. The State Council Information Office of the People’s Republic of China. Government white papers: medical and health services in China. Available from http://www.china-embassy.org/eng/zt/bps/t1001641.htm. Released December 29, 2012; accessed March 10, 2021.
12.	Chen XS, Jiang TT, Yin YP, et al. Circulating microRNAs as potential biomarkers in the diagnosis of neurosyphilis. Int J Dermatol Venereol 2020; 3(4):193-7. doi: 10.1097/JD9.0000000000000134. doi: 10.1097/JD9.0000000000000134
13.	The State Council Information Office of the People’s Republic of China. Medical and health services in China: white paper. Available from http://www.china-embassy.org/eng/zt/bps/t1001641.htm. Accessed February 15, 2021.
14.	Gong T, Shao Y, Liu J, et al. Treatment evaluation to improve preventing mother to child transmission among women with syphilis. Sci Rep 2019; 9(1):19547. doi: 10.1038/s41598-019-56095-6. doi: 10.1038/s41598-019-56095-6
15.	National Center for STD Control, China Centers for Disease Control and Prevention; Venereology Group, Chinese Society of Dermatology; Subcommittee on Venereology, China Dermatologist Association. Guidelines for the diagnosis and treatment of syphilis, gonorrhea, and genital chlamydial infection. Chin J Dermatol 2020; 53(3):168-79. Chinese. doi: 10.35541/cjd.20190808. doi: 10.35541/cjd.20190808
16.	Bureau of Disease Prevention and Control, National Health Commission of the People’s Republic of China. National overview of statutory infectious disease outbreaks in 2019. Available from http://www.nhc.gov.cn/jkj/s3578/202004/b1519e1bc1a944fc8ec176db600f68d1.shtml. Released April 20, 2020. Accessed February 15, 2021.
17.	Chen XS. Turning off the tap: sustaining elimination of congenital syphilis through the programme targeting high-risk groups. J Glob Health 2019; 9(2):020312. doi: 10.7189/jogh.09.020312. doi: 10.7189/jogh.09.020312
18.	World Hearlth Orgernization. Coronavirus disease (COVID-19) pandemic. Available from https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed February 25, 2022.
19.	Moreland A, Herlihy C, Tynan MA, et al. Timing of state and territorial COVID-19 stay-at-home orders and changes in population movement: United States, March 1 - May 31, 2020. MMWR Morb Mortal Wkly Rep 2020; 69(35):1198-203. doi: 10.15585/mmwr.mm6935a2. doi: 10.15585/mmwr.mm6935a2
20.	Czeisler M, Tynan MA, Howard ME, et al. Public attitudes, behaviors, and beliefs related to COVID-19, stay-at-home orders, nonessential business closures, and public health guidance—United States, New York City, and Los Angeles, May 5-12, 2020. MMWR Morb Mortal Wkly Rep 2020; 69(24):751-8. doi: 10.15585/mmwr.mm6924e1. doi: 10.15585/mmwr.mm6924e1
21.	Centers for Disease Control and Prevention. Guidance for businesses and employers responding to coronavirus disease 2019 (COVID-19). Available from https://www.cdc.gov/coronavirus/2019-ncov/community/guidance-business-response.html. Accessed September 20, 2021.
22.	Executive Office of the President. Declaring a National Emergency Concerning the Novel Coronavirus Disease (COVID-19) Outbreak. Daily J US Govern 2020; 85(53):15337-8. Available from https://www.federalregister.gov/documents/2020/03/18/2020-05794/declaring-a-national-emergency-concerning-the-novel-coronavirus-disease-covid-19-outbreak. Released March 18, 2020. Accessed September 20, 2021.
23.	Pagaoa M, Grey J, Torrone E, et al. Trends in nationally notifiable sexually transmitted disease case reports during the US COVID-19 pandemic, January to December 2020. Sex Transm Dis 2021; 48(10):798-804. doi: 10.1097/OLQ.0000000000001506. doi: 10.1097/OLQ.0000000000001506
24.	Sentís A, Prats-Uribe A, López-Corbeto E, et al. The impact of the COVID-19 pandemic on Sexually Transmitted Infections surveillance data: incidence drop or artefact? BMC Public Health 2021; 21(1):1637. doi: 10.1186/s12889-021-11630-x. doi: 10.1186/s12889-021-11630-x
25.	Härter G, Spinner CD, Roider J, et al. COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients. Infection 2020; 48(5):681-6. doi: 10.1007/s15010-020-01438-z. doi: 10.1007/s15010-020-01438-z pmid: 32394344
26.	Woodworth KR, Reynolds MR, Burkel V, et al. A preparedness model for mother-baby linked longitudinal surveillance for emerging threats. Matern Child Health J 2021; 25(2):198-206. doi: 10.1007/s10995-020-03106-y. doi: 10.1007/s10995-020-03106-y

[1]	张胜发,罗葳,马玉环,王志理,陈晶,周芳,张晓宇,周伟. 中国流动人口常见疾病及其影响因素：2017年横断面调查数据集[J]. Chinese Medical Sciences Journal, 2022, 37(3): 234-239.
[2]	杨涛莲, 钟华, 王卫, 王健伟. 中国医学科学院北京协和医学院科技创新十年回眸[J]. Chinese Medical Sciences Journal, 2022, 37(3): 240-45.
[3]	周学东. 国家战略与口腔医学的高质量发展[J]. Chinese Medical Sciences Journal, 2022, 37(2): 95-97.
[4]	张胜发, 罗葳, 董晓升, 陈文新, 伊向仁, 周伟, 张月, 赵远志. 中国青少年健康及健康行为数据集：一项山东省中学生的大规模纵向调查[J]. Chinese Medical Sciences Journal, 2022, 37(1): 60-66.
[5]	巩慧子, 吴梦茵, 李军, 郑和义. 万能模仿者：梅毒硬下疳的非典型皮肤表现[J]. Chinese Medical Sciences Journal, 2021, 36(4): 279-283.
[6]	宋兰, 朱振宸, 赵瑞杰, 李鹏昌, 田杜雪, 杜铁宽, 徐燕, 杨启文, 曹玮, 宋伟, 金征宇. 北京市单中心19例COVID-19患者的流行病学特征、影像学表现及临床转归[J]. Chinese Medical Sciences Journal, 2021, 36(2): 85-96.
[7]	吴斌,周江华,汪文鑫,杨慧琳,夏盟,张丙宏,折志刚,李红良. 高脂血症与新型冠状病毒肺炎住院患者28天全因死亡率的关系[J]. Chinese Medical Sciences Journal, 2021, 36(1): 17-26.
[8]	李大胜,王大为,王娜娜,徐海旺,黄河,董建平,夏晨. 北京首例由输入病例导致社区感染的新型冠状病毒肺炎患者：深度学习CT辅助诊断的作用[J]. Chinese Medical Sciences Journal, 2021, 36(1): 66-71.
[9]	杨坤芳, 孟琳懿, 张元凤, 杨永臣, 成鸿毅, 姜志虎, 张泓, 陈育才. 聚合酶γ基因（POLG）突变在中国汉族人口中可能罕见[J]. Chinese Medical Sciences Journal, 2020, 35(4): 350-356.
[10]	Vahid Damanpak Moghadam,Hamed Shafiee,Maryam Ghorbani,Reza Heidarifar. 新型冠状肺炎患者气管插管的补充建议[J]. Chinese Medical Sciences Journal, 2020, 35(2): 110-111.
[11]	宁晓红. 安宁缓和医疗在中国大陆地区发展的过去,现在和未来[J]. Chinese Medical Sciences Journal, 2018, 33(4): 199-203.
[12]	向奕蓉,宁晓红. 中国临床医生对舒缓医疗的认知调查[J]. Chinese Medical Sciences Journal, 2018, 33(4): 221-227.

优先出版

当期目次

过刊浏览

虚拟专题

作者中心

评阅者中心